CDMO Fujifilm Diosynth Opens $35 million Bioprocess Innovation Center in North Carolina's Research Triangle Park

SUGAR LAND--May 10, 2016--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--FUJIFILM Diosynth Biotechnologies U.S.A., Incorporated's (Morrisville, North Carolina), a Biologics Contract Development and Manufacturing Organization (CDMO), has opened its new $35 million Bioprocess Innovation Center in Research Triangle Park, North Carolina. The company offers pharma/bio companies contract development and manufacturing of recombinant proteins, vaccines, monoclonal antibodies, among other large molecules expressed in a wide array of microbial, mammalian, and insect cell line systems. Within this article: Describes new Bioprocess Innovation Center.